These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 4861327)
21. Mortality from asthma and bronchodilator aerosols. Campbell AH Med J Aust; 1976 Mar; 1(12):386-91. PubMed ID: 1272120 [TBL] [Abstract][Full Text] [Related]
22. [Effect of salbutamol and metaproterenol on patients with bronchial asthma]. Kolesár J; Eisner J Cas Lek Cesk; 1972 Aug; 111(33):789-91. PubMed ID: 5052544 [No Abstract] [Full Text] [Related]
23. Objective assessment of a bronchodilator drug combination in asthmatic outpatients. Mattila MJ; Alanko K Curr Ther Res Clin Exp; 1973 Jun; 15(6):273-84. PubMed ID: 4197251 [No Abstract] [Full Text] [Related]
24. Clinical evaluation of a bronchodilator-wetting agent aerosol. Miller J Ann Allergy; 1966 Sep; 24(9):492-5. PubMed ID: 5331330 [No Abstract] [Full Text] [Related]
25. Comparison of orciprenaline, ephedrine and methoxyphenamine as oral bronchodilators. Kerr A; Gebbie T N Z Med J; 1973 May; 77(492):320-2. PubMed ID: 4578811 [No Abstract] [Full Text] [Related]
26. [Study of an deptropine-isoprenaline aerosol. Comparison with other beonchodilators and a placebo]. Payfa M; Goossens A Acta Tuberc Pneumol Belg; 1966; 57(4):298-308. PubMed ID: 4859712 [No Abstract] [Full Text] [Related]
27. Review of sympathomimetic bronchodilators. Kaatz BL S D J Med; 1979 Mar; 32(3):9-12. PubMed ID: 375388 [No Abstract] [Full Text] [Related]
28. Sympathomimetic xanthine broncholysis in obstructive ventilatory disorders. Cohen BM; Elizabeth NJ Int J Clin Pharmacol; 1974 Jan; 9(1):6-15. PubMed ID: 4593130 [No Abstract] [Full Text] [Related]
29. The response to bronchodilator in asthmatic subjects: a comparison of various measures of flow rate. Sobol BJ; Baskette P; Dwyer K; Emirgil C Ann Allergy; 1975 Mar; 34(3):141-4. PubMed ID: 1124855 [No Abstract] [Full Text] [Related]
30. The response of asthmatics to bronchodilator aerosols. Sinclair JD N Z Med J; 1966 Aug; 65(408):524-7. PubMed ID: 5223727 [No Abstract] [Full Text] [Related]
31. [The effect of various dosage aerosols on asthmatic dyspnea (double-blind test)]. Illig H Med Klin; 1965 Sep; 60(36):1452-4. PubMed ID: 5324374 [No Abstract] [Full Text] [Related]
32. [Aerosols in the treatment of bronchial asthma]. Titscher R Wien Klin Wochenschr; 1972 Dec; 24(50):813-4. PubMed ID: 4565879 [No Abstract] [Full Text] [Related]
33. [Clinical pharmacology in the domain of pulmonology]. Renovanz HD Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):383-409. PubMed ID: 4395490 [No Abstract] [Full Text] [Related]
34. [Clinical pharmacology in the domain of pulmonology]. Renovanz HD Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 3(4):383-409. PubMed ID: 4394808 [No Abstract] [Full Text] [Related]
35. Anticholinergic and beta-sympathomimetic inhalation challenges in asthma and bronchitis. Marcq M; Minette A Acta Tuberc Pneumol Belg; 1976; 67(3-4):156-62. PubMed ID: 1016524 [No Abstract] [Full Text] [Related]
36. The prevention of exercise induced asthma. McCarthy OR Br J Dis Chest; 1972 Apr; 66(2):133-40. PubMed ID: 4624699 [No Abstract] [Full Text] [Related]
37. The bronchodilator effects of orciprenaline and salbutamol: a double-blind study. Racoveanu C; Stanescu DC; Manicatide M; Stroescu V Bull Physiopathol Respir (Nancy); 1970; 6(4):809-18. PubMed ID: 4940888 [No Abstract] [Full Text] [Related]
38. Assessment of bronchodilator drugs on asthmatic out-patients by daily measurements of the peak expiratory flow rate. Heaf PJ; Mattila MJ Arzneimittelforschung; 1969 Dec; 19(12):1927-9. PubMed ID: 4908261 [No Abstract] [Full Text] [Related]
39. [Bronchospasmolytic action of isoprenaline (Aleudrin) and orciprenaline (Alupent) in aerosol forms]. Aepli R Helv Med Acta; 1965 Nov; 32(4):511-8. PubMed ID: 5885402 [No Abstract] [Full Text] [Related]